Organisation paid for research Program year 2023 Source: CMS Open Payments

Graystone Eye

Neither a doctor nor a teaching hospital

Research payments

$173,466

8 payments

Through program year 2023, Graystone Eye is reported as receiving $173,466 in research payments, across 8 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$187	1
2022	Research	$256	1
2021	Research	$94,763	2
2020	Research	$65,120	3
2019	Research	$13,140	1

Breakdown

Who paid Research payments · program years 2019–2023

Novartis Pharmaceuticals Corporation $173,466 8 payments

Studies the money was for Research payments · program years 2019–2023

A 64-Week, Phase 3B, Multi-Center Study Assessing the Efficacy and Safety of Brolucizumab 6Mg Compared to Aflibercept 2Mg in A Treat to Control Regimen in Patients With Neovascular Age-Related MacUlar Degeneration $108,320 6 payments
A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab VS. Aflibercept in Patients With Visual Impairment Due to Diabetic MacUlar Edema (Kingfisher) $65,146 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.